Alector, Inc.
General ticker "ALEC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $177.3M (TTM average)
Alector, Inc. follows the US Stock Market performance with the rate: 34.3%.
Estimated limits based on current volatility of 6.2%: low 2.00$, high 2.26$
Factors to consider:
- Total employees count: 238 (-2.5%) as of 2024
- Top business risk factors: Economic downturns and volatility, Limited operating history, Clinical trial delays, Labor/talent shortage/retention, Market volatility
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.00$, 2.98$]
- 2026-12-31 to 2027-12-31 estimated range: [1.22$, 3.37$]
Financial Metrics affecting the ALEC estimates:
- Positive: with PPE of -1.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -123.22 <= 0.01
- Positive: Investing cash flow per share per price, % of 131.64 > -0.63
- Positive: Inventory ratio change, % of -5.06 <= -0.75
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term ALEC quotes
Long-term ALEC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $97.06MM | $100.56MM | $21.05MM |
| Operating Expenses | $248.80MM | $245.56MM | $177.05MM |
| Operating Income | $-151.74MM | $-145.00MM | $-156.01MM |
| Non-Operating Income | $26.56MM | $26.08MM | $13.25MM |
| R&D Expense | $192.12MM | $185.94MM | $123.06MM |
| Income(Loss) | $-125.18MM | $-118.92MM | $-142.76MM |
| Taxes | $5.21MM | $0.13MM | $0.17MM |
| Profit(Loss)* | $-130.39MM | $-119.05MM | $-142.93MM |
| Stockholders Equity | $134.16MM | $126.80MM | $30.65MM |
| Assets | $621.83MM | $468.30MM | $293.24MM |
| Operating Cash Flow | $-184.16MM | $-229.91MM | $-184.03MM |
| Capital expenditure | $2.38MM | $1.25MM | $0.04MM |
| Investing Cash Flow | $101.92MM | $107.13MM | $196.60MM |
| Financing Cash Flow | $2.55MM | $81.54MM | $20.21MM |
| Earnings Per Share** | $-1.56 | $-1.23 | $-1.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.